Buydens P, Debeuckelaere S. Efficacy of SF 68 in the treatment of acute diarrhea. A placebo-controlled trial.
Scand J Gastroenterol.
1996;31:887-891.
Scarpignato C, Rampal P. Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.
Chemotherapy.
1995;41(suppl 1):48-81.
Hilton E, Kolakowski P, Singer C, et al. Efficacy of
Lactobacillus GG
as a diarrheal preventive in travelers.
J Travel Med.
1997;4:41-43.
Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of traveller's diarrhoea by
Lactobacillus GG.
Ann Med.
1990;22:53-56.
Kirchhelle VA, Fruhwein N, Toburen D. Treatment of persistent diarrhea with
Saccharomyces boulardii. Results of a prospective study [in German; English abstract].
Fortschr Med.
1996;114:136-140.
Kollaritsch VH, Holst H, Grobara P, et al. Prevention of traveler's diarrhea with
Saccharomyces boulardii. Results of a placebo-controlled double-blind study [translated from German].
Fortschr Med.
1993;111:152-156.
Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections.
JAMA.
1996;275:870-876.
Guandalini S, Pensabene L, Zikri MA, et al.
Lactobacillus GG
administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial.
J Pediatr Gastroenterol Nutr.
2000;30:54-60.
Oberhelman RA, Gilman RH, Sheen P, et al. A placebo-controlled trial of
Lactobacillus GG
to prevent diarrhea in undernourished Peruvian children.
J Pediatr.
1999;134:15-20.
Costa-Ribeiro H, Ribeiro TC, Mattos AP, et al. Limitations of probiotic therapy in acute, severe dehydrating diarrhea.
J Pediatr Gastroenterol Nutr. 2003;36:112-115.
Colombel JF, Cortot A, Neut C, et al. Yoghurt with
Bifidobacterium longum
reduces erythromycin-induced gastrointestinal effects.
Lancet.
1987;2:43.
Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by
Saccharomyces boulardii: a prospective study.
Gastroenterology.
1989;96:981-988.
Surawicz CM, McFarland LV, Elmer G, et al. Treatment of recurrent
Clostridium difficile
colitis with vancomycin and
Saccharomyces boulardii.
Am J Gastroenterol.
1989;84:1285-1287.
McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by
Saccharomyces boulardii
compared with placebo.
Am J Gastroenterol.
1995;90:439-448.
Arvola T, Laiho K, Torkkeli S, et al. Prophylactic
Lactobacillus GG
reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study.
Pediatrics.
1999;104:e64.
Siitonen S, Vapaatalo H, Salminen S, et al. Effect of
Lactobacillus GG
yoghurt in prevention of antibiotic associated diarrhoea.
Ann Med.
1990;22:57-59.
Vanderhoof JA, Whitney DB, Antonson DL, et al.
Lactobacillus GG
in the prevention of antibiotic-associated diarrhea in children.
J Pediatr.
1999;135:564-568.
Thomas MR, Litin SC, Osmon DR, et al. Lack of effect of
Lactobacillus GG
on antibiotic-associated diarrhea: a randomized, placebo-controlled trial.
Mayo Clin Proc.
2001;76:883-889.
Tankanow RM, Ross MB, Ertel IJ, et al. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea.
DICP.
1990;24:382-384.
Urbancsek H, Kazar T, Mezes I, et al. Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea.
Eur J Gastroenterol Hepatol.
2001;13:391-396.
Unger C, Haring B, Kruse A, et al. Double-blind randomised placebo-controlled phase III study of an
E. coli
extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer.
Arzneimittelforschung.
2001;51:332-338.
Elmer GW, Moyer KA, Vega R, et al. Evaluation of
Saccharomyces boulardii
for patients with HIV-related diarrhoea and in healthy volunteers receiving antifungals.
Microecol Ther.
1995;25:23-31.
Bleichner G, Blehaut H, Mentec H, et al.
Saccharomyces boulardii
prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind, placebo-controlled trial.
Intensive Care Med.
1997;23:517-523.
Plein K, Hotz J. Therapeutic effects of
Saccharomyces boulardii
on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea—a pilot study.
Z Gastroenterol.
1993;31:129-134.
Madden JA, Hunter JO. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics.
Br J Nutr.
2002;88(suppl 1):S67-S72.
Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic
Escherichia coli
versus mesalazine for the treatment of ulcerative colitis: a randomised trial.
Lancet.
1999;354:635-639.
Faubion WA, Sandborn WJ. Probiotic therapy with
E. coli
for ulcerative colitis: take the good with the bad.
Gastroenterology.
2000;118:630-631.
Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials.
J Pediatr Gastroenterol Nutr.
2001;33(suppl 4):S17-S25.
Ashraf H, Mahalanabis D, Mitra AK, et al. Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial.
Acta Paediatr.
2001;90:1373-1378.
Casswall TH, Sarker SA, Albert MJ, et al. Treatment of
Helicobacter pylori
infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum.
Aliment Pharmacol Ther.
1998;12:563-568.
Casswall TH, Sarker SA, Faruque SM, et al. Treatment of enterotoxigenic and enteropathogenic
Escherichia coli
-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial.
Scand J Gastroenterol.
2000;35:711-718.
Freedman DJ, Tacket CO, Delehanty A, et al. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic
Escherichia coli.J Infect Dis. 1998;177:662-667.
Greenberg PD, Cello JP. Treatment of severe diarrhea caused by
Cryptosporidium parvum
with oral bovine immunoglobulin concentrate in patients with AIDS.
J Acquir Immune Defic Syndr Hum Retrovirol.
1996;13:348-354.
Mitra AK, Mahalanabis D, Ashraf H, et al. Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: a double-blind, controlled clinical trial.
Acta Paediatr.
1995;84:996-1001.
Okhuysen PC, Chappell CL, Crabb J, et al. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with
Cryptosporidium parvum.
Clin Infect Dis.
1998;26:1324-1329.
Plettenberg A, Stoehr A, Stellbrink HJ, et al. A preparation from bovine colostrum in the treatment of HIV-positive patients with chronic diarrhea.
Clin Investig.
1993;71:42-45.
Sarker SA, Casswall TH, Mahalanabis D, et al. Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum.
Pediatr Infect Dis J.
1998;17:1149-1154.
Tacket CO, Binion SB, Bostwick E, et al. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after
Shigella flexneri
challenge.
Am J Trop Med Hyg.
1992;47:276-283.
Tacket CO, Losonsky G, Link H, et al. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic
Escherichia coli.
N Engl J Med.
1988;318:1240-1243.
Ylitalo S, Uhari M, Rasi S, et al. Rotaviral antibodies in the treatment of acute rotaviral gastroenteritis.
Acta Paediatr.
1998;87:264-267.
Ashraf H, Rahman MM, Fuchs GJ, Mahalanabis D. Folic acid in the treatment of acute watery diarrhoea in children: a double-blind, randomized, controlled trial.
Acta Pædiatr.
1998;87:1113-1115.
Haffejee IE. Effect of oral folate on duration of acute infantile diarrhoea [letter].
Lancet.
1988;2:334-335.
Rabbani GH, Teka T, Zaman B, et al. Clinical studies in persistent diarrhea: dietary management with green banana or pectin in Bangladeshi children.
Gastroenterology.
2001;121:554-560.
Loeb H, Vandenplas Y, Wursch P, Guesry P. Tannin-rich carob pod for the treatment of acute-onset diarrhea.
J Pediatr Gastroenterol Nutr.
1989;8:480-485.
Eherer AJ, Santa Ana CA, Porter J, et al. Effect of psyllium, calcium polycarbophil, and wheat bran on secretory diarrhea induced by phenolphthalein.
Gastroenterology.
1993;104:1007-1012.
Holodniy M, Koch J, Mistal M, et al. A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS.
Am J Gastroenterol.
1999;94:3267-3273.
Wanke CA, Pleskow D, Degirolami PC, et al. A medium chain triglyceride-based diet in patients with HIV and chronic diarrhea reduces diarrhea and malabsorption: a prospective, controlled trial.
Nutrition.
1996;12:766-771.
Grant J, Mahanty S, Khadir A, et al. Wheat germ supplement reduces cyst and trophozoite passage in people with giardiasis.
Am J Trop Med Hyg. 2001;65:705-710.
Meyer-Wegener J, Paulus M. Immune-stimulating therapy with
Eleutherococcus senticosus
for antibiotic-induced diarrhea [in German; English abstract].
Med Welt.
1997;48:493-496.
Izadnia F, Wong CT, Kocoshis SA. Brewer’s yeast and
Saccharomyces boulardii
both attenuate
Clostridium difficile
-induced colonic secretion in the rat.
Dig Dis Sci.
1998;43:2055-2060.
Schellenberg D, Bonington A, Champion C, et al. Treatment of
Clostridium difficile
diarrhea with brewer’s yeast [letter].
Lancet.
1994;343:171-172.
Rabbani GH, Butler T, Knight J, et al. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic
Escherichia coli
and
Vibrio cholerae.
J Infect Dis.
1987;155:979-984.
James JM, Burks AW. Food-associated gastrointestinal disease.
Curr Opin Pediatr.
1996;8:471-475.
Swagerty DL Jr, Walling AD, Klein RM. Lactose intolerance.
Am Fam Physician.
2002;65:1845-1850.
Personal experience on acupuncture treatment of diarrhea.
J Tradit Chin Med.
1990;10:163-167.
Feng WL. Acupuncture treatment for 30 cases of infantile chronic diarrhea.
J Tradit Chin Med.
1989;9:106-107.
Lin Y, Zhou Z, Shen W, et al. Clinical and experimental studies on shallow needling technique for treating childhood diarrhea.
J Tradit Chin Med.
1993;13:107-114.
Lin YC. Observation of therapeutic effects of acupuncture treatment in 170 cases of infantile diarrhea.
J Tradit Chin Med.
1987;7:203-204.
Su Z. Acupuncture treatment of infantile diarrhea: a report of 1050 cases.
J Tradit Chin Med.
1992;12:120-121.
Thibault H, Aubert-Jacquin C, Goulet O. Effects of long-term consumption of a fermented infant formula (with
Bifidobacterium breve
C50 and
Streptococcus thermophilus
065) on acute diarrhea in healthy infants.
J Pediatr Gastroenterol Nutr. 2004;39:147-152.
Wullt M, Hagslatt ML, Odenholt I.
Lactobacillus plantarum
299v for the treatment of recurrent
Clostridium difficile
-associated diarrhoea: a double-blind, placebo-controlled trial.
Scand J Infect Dis. 2003;35:365-7.
Beniwal RS, Arena VC, Thomas L, et al. A randomized trial of yogurt for prevention of antibiotic-associated diarrhea.
Dig Dis Sci. 2003;48:2077-2082.
Mansour-Ghanaei F, Dehbashi N, Yazdanparast K, Shafaghi A. Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis.
World J Gastroenterol. 2003;9:1832-1833.
Subbotina MD, Timchenko VN, Vorobyov MM, et al. Effect of oral administration of tormentil root extract (
Potentilla tormentilla) on rotavirus diarrhea in children: a randomized, double blind, controlled trial.
Pediatr InfectDis J. 2003;22:706-710.
Kuge T, Shibata T, Willett MS, et al. Multicenter, double-blind, randomized comparison of wood creosote, the principal active ingredient of Seirogan, an herbal antidiarrheal medication, and loperamide in adults with acute nonspecific diarrhea.
Clin Ther. 2004;26:1644-1651.
Kuge T, Shibata T, Willett MS. Wood creosote, the principal active ingredient of seirogan, an herbal antidiarrheal medicine: a single-dose, dose-escalation safety and pharmacokinetic study.
Pharmacotherapy. 2003;23:1391-1400.
Cummings JH, Christie S, Cole TJ. A study of fructo oligosaccharides in the prevention of travellers' diarrhoea.
Aliment Pharmacol Ther.
2001;15:1139-1145
Kotowska M, Albrecht P, Szajewska H,et al. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.
Aliment Pharmacol Ther.
2005;21:583-590.
Kurugol Z, Koturoglu G. Effects of Saccharomyces boulardii in children with acute diarrhoea.
Acta Paediatr.
2005;94:44-47.
McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
Am J Gastroenterol.
2006;101:812-822
Bousvaros A, Guandalini S, Baldassano RN, et al. A Randomized, Double-blind Trial of Lactobacillus GG Versus Placebo in Addition to Standard Maintenance Therapy for Children with Crohn's Disease.
Inflamm Bowel Dis. 2005;11:833-839.
Marteau P, Lemann M, Seksik P, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double-blind, placebo-controlled GETAID trial.
Gut.
2005 Dec 23 [Epub ahead of print].
Leung WK, Wu JC, Liang SM, et al. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
Am J Gastroenterol.
2006;101:1574-1580.
Becker B, Kuhn U, Hardewig-Budny B. Double-blind, randomized evaluation of clinical efficacy and tolerability of an apple pectin-chamomile extract in children with unspecific diarrhea.
Arzneimittelforschung. 2006;56:387-393.
Szajewska H, Ruszczynski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trials.
J Pediatr.
2006;149:367-372.
Briand V, Buffet P, Genty S, et al. Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study.
Clin Infect Dis.
2006;43:1170-1175.
Wullt M, Johansson Hagslatt ML, Odenholt I, et al. Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent
Clostridium difficile
-associated diarrhea.
Dig Dis Sci. 2007 Apr 10 [Epub ahead of print].
Zaman S, Mannan J, Lange S, et al. B 221, a medical food containing antisecretory factor reduces child diarrhoea: a placebo controlled trial.
Acta Paediatr.
2007;96:1655-1659.
Beausoleil M, Fortier N, Guenette S, et al. Effect of a fermented milk combining lactobacillus acidophilus Cl1285 and lactobacillus casei in the prevention of antibiotic-associated diarrhea: A randomized, double-blind, placebo-controlled trial.
Can J Gastroenterol.
2007;21:732-736.
Mao M, Yu T, Xiong Y, et al. Effect of a lactose-free milk formula supplemented with bifidobacteria and streptococci on the recovery from acute diarrhoea.
Asia Pac J Clin Nutr.
2008;17:30-34.
Ruszczynski M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of
Lactobacillus rhamnosus
(strains E/N, Oxy, and Pen) in the prevention of antibiotic-associated diarrhea in children.
Aliment Pharmacol Ther.
2008 Apr 13.
Alfaleh K, Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants.
Cochrane Database of Systematic Reviews.
2008;(1):CD005496.
Henker J, Laass MW, Blokhin BM, et al. Placebo versus probiotic
Escherichia coli
Nissle 1917 for treating diarrhea of greater than 4 days duration in infants and toddlers.
Pediatr Infect Dis J.
2008 May 8.
Guandalini S. Probiotics for children with diarrhea: an update.
J Clin Gastroenterol.
2008 May 23.
Patro B, Golicki D, Szajewska H. Meta-analysis: zinc supplementation for acute gastroenteritis in children.
Aliment Pharmacol Ther.
2008 Jul 1. [Epub ahead of print]
Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children.
Cochrane Database Syst Rev.
2008;CD005436.
Lin HC, Hsu CH, Chen HL, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial.
Pediatrics.
2008;122:693-700.
Hickson M, D'Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, Bulpitt CJ. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial.
BMJ.
2007;335(7610):80.
Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients.
Am J Gastroenterol.
2010;105(7):1636-1641.
Allen S, Martinez E, Gregorio G, Dans L. Probiotics for treating acute infectious diarrhea.
Cochrane Database Syst Rev.
2010;(12):CD003048.
Aponte G, Mancilla C, Pariasca N, Galarza R. Probiotics for treating persistent diarrhoea in children.
Cochrane Database Syst Rev.
2010;(11):CD007401.
Cimperman L, Bayless G, Best K, et al. A randomized, double-blind, placebo-controlled pilot study of
Lactobacillus reuteri
ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults.
J Clin Gastroenterol. 2011 May 5.
Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Cochrane Database Syst Rev.
2011;11:CD004827.
Corrêa NB, Penna FJ, Lima FM, Nicoli JR, Filho LA. Treatment of acute diarrhea with Saccharomyces boulardii in infants.
J Pediatr Gastroenterol Nutr.
2011;53(5):497-501.
Videlock EJ, Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhoea.
Aliment Pharmacol Ther.
2012;35(12):1355-1369.
Johnston BC, Ma SS, Goldenberg JZ. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis.
Ann Intern Med. 2012;157(12):878-888.
Francavilla R, Lionetti E, et al. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea--a double-blind study.
Aliment Pharmacol Therap. 2012;36(4):363-369.
Last reviewed July 2012 by EBSCO CAM Review Board
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.